Enhanced Surveillance for New Vaccine Preventable Diseases
The summary for the Enhanced Surveillance for New Vaccine Preventable Diseases grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Enhanced Surveillance for New Vaccine Preventable Diseases: The purpose of this announcement is to solicit applications for a research cooperative agreement that will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among asymptomatic healthy controls. Funded activities for this Core Component award will include the provision of a US pediatric vaccine-preventable (and potentially vaccine preventable) disease surveillance system for a wide variety of AGE and ARI pathogens, evaluations of vaccine effectiveness for licensed vaccines including rotavirus and influenza, burden and natural history of disease for pathogens having upcoming and/or new vaccines, pediatric infectious disease transmission dynamics, informing vaccination/therapeutic policy and development, vaccine impacts for targeted and vulnerable populations, and socioeconomic and microbiological environments potentially relevant to these public health interventions. A second purpose of this announcement is to prospectively follow a birth cohort to the second birthday to incorporate a natural history study of pathogens and immunologic factors related to symptomatic and asymptomatic infection in US infants/young children. This second purpose/activity will be a separate Optional Component of the application, independently scored, that will be awarded to an applicant that has been competitively awarded a Core Component award.
Federal Grant Title: | Enhanced Surveillance for New Vaccine Preventable Diseases |
Federal Agency Name: | Centers for Disease Control and Prevention |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | CDC-RFA-IP-16-004 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.185 |
CFDA Descriptions: | Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
Current Application Deadline: | Jan 15, 2016 |
Original Application Deadline: | Jan 15, 2016 |
Posted Date: | Nov 13, 2015 |
Creation Date: | Nov 13, 2015 |
Archive Date: | Feb 14, 2016 |
Total Program Funding: | $38,600,000 |
Maximum Federal Grant Award: | $1,000,000 |
Minimum Federal Grant Award: | $800,000 |
Expected Number of Awards: | 7 |
Cost Sharing or Matching: | No |
- Category Explanation
- a
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Eligibility Category:
The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education:
Hispanic-serving Institutions
Historically Black Colleges and Universities (HBCUs)
Tribally Controlled Colleges and Universities (TCCUs)
Alaska Native and Native Hawaiian Serving Institutions
Nonprofits Other Than Institutions of Higher Education:
Nonprofits (Other than Institutions of Higher Education)
Governments:
Eligible Agencies of the Federal Government U.S. Territory or Possession
Other:
Native American tribal organizations (other than Federally recognized tribal governments)
Faith-based or Community-based Organizations
Regional Organizations
Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment
Forms" when submitting via www.grants.gov.
Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency's existing in-house or contractor resources. FFRDC's enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to http:// ecfr.gpoaccess.gov /cgi/t/text/ text-idx?c=ecfr&
sid=512ff78311f427c00454772dcf21523a&rgn=div8
- Grant Announcement Contact
- PGOTIM
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO)
Technical Informaiton Management Section (TIMS)
2960 Brandywine Road
Mail Stop K-98
Atlanta, GA 30341
Office phone: 770-488-2700
Fax: 770-488-8350
[email protected]
Centers for Disease Control and Prevention 770-488-2756 - Similar Government Grants
- • Partnerships to Enhance Immunization Information Systems (IIS)
- • Advancing the capacity of immunization program managers through a national coordinating or...
- • Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health...
- • Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narrativ...
- • Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
- • Coordination of Activities Between the CDC's National Immunization Program and the State a...
- • National Minority Organizations Immunization Projects
- • Using Provider Partnerships to Strengthen the Immunization Message
- More Grants from the Centers for Disease Control and Prevention
- • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...
- • Strengthening Public Health Systems and Services through National Partnerships to Improve ...
- • 93.067
- • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
- • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...